JP2015525754A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015525754A5 JP2015525754A5 JP2015521001A JP2015521001A JP2015525754A5 JP 2015525754 A5 JP2015525754 A5 JP 2015525754A5 JP 2015521001 A JP2015521001 A JP 2015521001A JP 2015521001 A JP2015521001 A JP 2015521001A JP 2015525754 A5 JP2015525754 A5 JP 2015525754A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutical composition
- liquid aqueous
- aqueous pharmaceutical
- ylethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 31
- 239000007788 liquid Substances 0.000 claims 20
- 239000008194 pharmaceutical composition Substances 0.000 claims 19
- 150000003839 salts Chemical class 0.000 claims 13
- 206010028980 Neoplasm Diseases 0.000 claims 8
- ODIUNTQOXRXOIV-UHFFFAOYSA-N 1-[6-[[6-(4-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl]-1,3-benzothiazol-2-yl]-3-(2-morpholin-4-ylethyl)urea Chemical compound C1=CC(F)=CC=C1C1=NN2C(SC=3C=C4SC(NC(=O)NCCN5CCOCC5)=NC4=CC=3)=NN=C2C=C1 ODIUNTQOXRXOIV-UHFFFAOYSA-N 0.000 claims 7
- 229920000858 Cyclodextrin Polymers 0.000 claims 7
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims 7
- 201000011510 cancer Diseases 0.000 claims 5
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims 4
- -1 6-{[6- (4-fluorophenyl) [1,2,4] triazolo [4,3-b] pyridazin-3-yl] sulfanyl} -1,3-benzothiazol-2-yl Chemical group 0.000 claims 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 4
- 125000003396 thiol group Chemical group [H]S* 0.000 claims 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 3
- 238000002347 injection Methods 0.000 claims 3
- 239000007924 injection Substances 0.000 claims 3
- 125000002206 pyridazin-3-yl group Chemical group [H]C1=C([H])C([H])=C(*)N=N1 0.000 claims 3
- 229910052708 sodium Inorganic materials 0.000 claims 3
- 239000011734 sodium Substances 0.000 claims 3
- 229940097346 sulfobutylether-beta-cyclodextrin Drugs 0.000 claims 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 2
- 101150105382 MET gene Proteins 0.000 claims 2
- 238000001802 infusion Methods 0.000 claims 2
- 239000011780 sodium chloride Substances 0.000 claims 2
- 239000000243 solution Substances 0.000 claims 2
- 208000037844 advanced solid tumor Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 238000001990 intravenous administration Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 230000000750 progressive effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12305840.6 | 2012-07-12 | ||
| EP12305840 | 2012-07-12 | ||
| PCT/EP2013/064741 WO2014009500A1 (en) | 2012-07-12 | 2013-07-11 | Anti-tumoral composition comprising the compound 1-(6-{[6-(4-fluorophenyl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}-1,3-benzothiazol-2-yl)-3-(2-morpholin-4-ylethyl)urea |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015525754A JP2015525754A (ja) | 2015-09-07 |
| JP2015525754A5 true JP2015525754A5 (enExample) | 2016-08-12 |
Family
ID=48782350
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015521001A Pending JP2015525754A (ja) | 2012-07-12 | 2013-07-11 | 化合物１−（６−｛［６−（４−フルオロフェニル）［１，２，４］トリアゾロ［４，３−ｂ］ピリダジン−３−イル］スルファニル｝−１，３−ベンゾチアゾール−２−イル）−３−（２−モルホリン−４−イルエチル）尿素を含む抗腫瘍組成物 |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US20150119391A1 (enExample) |
| EP (1) | EP2872119A1 (enExample) |
| JP (1) | JP2015525754A (enExample) |
| KR (1) | KR20150030761A (enExample) |
| CN (1) | CN104470500A (enExample) |
| AR (1) | AR091727A1 (enExample) |
| AU (1) | AU2013288676A1 (enExample) |
| BR (1) | BR112015000497A2 (enExample) |
| CA (1) | CA2878500A1 (enExample) |
| CL (1) | CL2015000074A1 (enExample) |
| CO (1) | CO7160069A2 (enExample) |
| CR (1) | CR20150005A (enExample) |
| EA (1) | EA201590199A1 (enExample) |
| HK (1) | HK1209642A1 (enExample) |
| IL (1) | IL236662A0 (enExample) |
| IN (1) | IN2015KN00075A (enExample) |
| MA (1) | MA37753B1 (enExample) |
| MX (1) | MX2015000532A (enExample) |
| PH (1) | PH12015500060A1 (enExample) |
| SG (1) | SG11201500123XA (enExample) |
| TN (1) | TN2015000011A1 (enExample) |
| TW (1) | TW201402121A (enExample) |
| UY (1) | UY34909A (enExample) |
| WO (1) | WO2014009500A1 (enExample) |
| ZA (1) | ZA201500129B (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2024544083A (ja) * | 2021-12-15 | 2024-11-27 | シルラジェン，インコーポレイテッド | 修飾ベータ－シクロデキストリンを含む医薬組成物 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9711643D0 (en) * | 1997-06-05 | 1997-07-30 | Janssen Pharmaceutica Nv | Glass thermoplastic systems |
| FR2817750B1 (fr) * | 2000-12-11 | 2003-02-21 | Sanofi Synthelabo | Composition pharmaceutique de dronedarone pour administration parenterale |
| JP4817068B2 (ja) * | 2003-01-14 | 2011-11-16 | イエダ・リサーチ・アンド・ディベロップメント・カンパニー・リミテッド | 全身性エリテマトーデスの治療のためのペプチドの非経口製剤 |
| PA8792501A1 (es) * | 2007-08-09 | 2009-04-23 | Sanofi Aventis | Nuevos derivados de 6-triazolopiridacina-sulfanil benzotiazol y bencimidazol,su procedimiento de preparación,su aplicación como medicamentos,composiciones farmacéuticas y nueva utilización principalmente como inhibidores de met. |
| CA2716720A1 (en) * | 2008-02-28 | 2009-09-03 | Takeda Pharmaceutical Company Limited | Pharmaceutical composition |
| CN101444510B (zh) * | 2008-12-31 | 2011-03-09 | 南京卡文迪许生物工程技术有限公司 | 含有伏立康唑的药物制剂及其制备方法 |
| FR2941951B1 (fr) * | 2009-02-06 | 2011-04-01 | Sanofi Aventis | Derives de 6-(6-nh-substitue-triazolopyridazine-sulfanyl) benzothiazoles et benzimidazoles : preparation, application comme medicaments et utilisation comme inhibiteurs de met. |
-
2013
- 2013-07-11 WO PCT/EP2013/064741 patent/WO2014009500A1/en not_active Ceased
- 2013-07-11 JP JP2015521001A patent/JP2015525754A/ja active Pending
- 2013-07-11 TW TW102124952A patent/TW201402121A/zh unknown
- 2013-07-11 KR KR20157003404A patent/KR20150030761A/ko not_active Withdrawn
- 2013-07-11 CA CA 2878500 patent/CA2878500A1/en not_active Abandoned
- 2013-07-11 AU AU2013288676A patent/AU2013288676A1/en not_active Abandoned
- 2013-07-11 MX MX2015000532A patent/MX2015000532A/es unknown
- 2013-07-11 AR ARP130102458 patent/AR091727A1/es unknown
- 2013-07-11 MA MA37753A patent/MA37753B1/fr unknown
- 2013-07-11 HK HK15110497.0A patent/HK1209642A1/xx unknown
- 2013-07-11 EP EP13735312.4A patent/EP2872119A1/en not_active Withdrawn
- 2013-07-11 IN IN75KON2015 patent/IN2015KN00075A/en unknown
- 2013-07-11 CN CN201380037070.8A patent/CN104470500A/zh active Pending
- 2013-07-11 EA EA201590199A patent/EA201590199A1/ru unknown
- 2013-07-11 SG SG11201500123XA patent/SG11201500123XA/en unknown
- 2013-07-11 BR BR112015000497A patent/BR112015000497A2/pt not_active IP Right Cessation
- 2013-07-12 UY UY34909A patent/UY34909A/es not_active Application Discontinuation
-
2015
- 2015-01-07 CR CR20150005A patent/CR20150005A/es unknown
- 2015-01-08 TN TNP2015000011A patent/TN2015000011A1/fr unknown
- 2015-01-08 CO CO15004112A patent/CO7160069A2/es unknown
- 2015-01-08 ZA ZA2015/00129A patent/ZA201500129B/en unknown
- 2015-01-09 US US14/593,059 patent/US20150119391A1/en not_active Abandoned
- 2015-01-09 PH PH12015500060A patent/PH12015500060A1/en unknown
- 2015-01-09 CL CL2015000074A patent/CL2015000074A1/es unknown
- 2015-01-11 IL IL236662A patent/IL236662A0/en unknown